USE OF INHIBITORS OF ATP-SENSITIVE POTASSIUM CHANNELS FOR THE TREATMENT OF HEARING LOSS

摘要

The present invention relates to the use of inhibitors of ATP-sensitive potassium channels for the protective (including preventive) therapy or the reduced progression of hearing loss, in particular age-related hearing loss (presbycusis) and/or noise-induced hearing loss (NIHL). Preferred is the systemic or local administration of clinically established sulfonylureas, such as, for example, glibenclamide.